ロード中...
Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway
BACKGROUND: Diabetic nephropathy (DN) is the leading cause of end-stage renal failure, contributing to severe morbidity and mortality in diabetic patients. Berberine (BBR) has been well characterized to exert renoprotective effects in DN progression. However, the action mechanism of BBR in DN remain...
保存先:
| 出版年: | Biol Res |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5878418/ https://ncbi.nlm.nih.gov/pubmed/29604956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40659-018-0157-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|